Cite
HARVARD Citation
Gold, R. et al. (2018). Incidence and mitigation of gastrointestinal events in patients with relapsing–remitting multiple sclerosis receiving delayed-release dimethyl fumarate: a German phase IV study (TOLERATE). Therapeutic advances in neurological disorders. p. . [Online].